title: The ABG hydroxyapatite-coated hip prosthesis: one hundred consecutive operations with average 6-year follow-up.
abstract: One hundred consecutive ABG (Anatomique Benoist Giraud, Howmedica) hydroxyapatite-coated hip arthroplasties in 97 patients were evaluated prospectively with a follow-up time of 4 to 10 years (mean, 6 years). Clinical results were excellent with an improvement in the Merle d'Aubigne score from 9 preoperatively to 17.4 at 5 years. Thigh pain was persistent in only 3%; it was mild in nature and controlled with simple analgesics. Kaplan-Meyer survivorship analysis was 100% for the femoral stem and 95% for the acetabular cup at 6 years. Of concern was the high polyethylene wear measured with an average of 0.24 mm/y (range, 0.05-0.76 mm/y).
authors.affiliation: FRCS (TR ORTH), Newport, UK.
authors.forename: A
authors.initials: A
authors.lastname: Rogers
authors.forename: R
authors.initials: R
authors.lastname: Kulkarni
authors.forename: E M
authors.initials: EM
authors.lastname: Downes
mesh_terms: D000328:Adult; D000368:Aged; D019644:Arthroplasty, Replacement, Hip; D001672:Biocompatible Materials / Q000627:therapeutic use; D017886:Durapatite / Q000627:therapeutic use; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D015207:Osteoarthritis, Hip / Q000601:surgery; D011475:Prosthesis Failure; D012086:Reoperation; D016896:Treatment Outcome
chemical_list: D001672:Biocompatible Materials; D017886:Durapatite